The regulatory role of nerve growth factor and its receptor system in fibroblastlike synovial cells

Scandinavian Journal of Rheumatology

Volumn 38, Issue 3, 2009, Pages 207-215

  Raychaudhuri, S P ^a,b   Raychaudhuri, S K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE A; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL COUNT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST CULTURE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MORBIDITY; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIOCYTE; ARTHRITIS; CELL CULTURE; CELL DIVISION; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; FIBROBLAST; FLOW CYTOMETRY; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; SYNOVIUM;

ARTHRITIS; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; CELL DIVISION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-1BETA; NERVE GROWTH FACTOR; OSTEOARTHRITIS; RECEPTOR CROSS-TALK; RECEPTOR, NERVE GROWTH FACTOR; RECEPTOR, TRKA; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 65649117831     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740802448866     Document Type: Article

References (40)

1. Aloe L. Nerve growth factor and neuroimmune responses: basic and clinical observations. Arch Physiol Biochem 2001;109:354-356
2. Hattori A, Iwasaki S, Murase K, Tsujimoto M, Sato M, Hayashi K, et al. Tumor necrosis factor is markedly synergistic with interleukin 1 and interferon gamma in stimulating the production of nerve growth factor in fibroblasts. FEBS Lett 1994;340:177-180
3. Heese K, Hock C, Otten U. Inflammatory signals induce neurotrophin expression in human microglial cells. J Neurochem 1998;70:699-707.
4. Farber EM, Raychaudhuri SP. Is psoriasis a neuroimmunologic disease? Int J Dermatol 1999;38:12-15.
5. Waller HA, Butler MG, McClean JG, Dowd GS, Scott DL. Localisation of fibronectin mRNA in the rheumatoid synovium by in situ hybridisation. Ann Rheum Dis 1992;51: 735-740
6. Henderson B, Pettipher ER. The synovial lining cell: biology and pathobiology. Semin Arthritis Rheum 1985;15:1-32.
7. Aloe L, Probert L, Kollias G, Bracci-Laudiero L, Spillantini MG, Levi-Montalcini R. The synovium of transgenic arthritic mice expressing human tumor necrosis factor contains a high level of nerve growth factor. Growth Factors 1993;9:149-155 (Pubitemid 23258951)
8. Manni L, Lundeberg T, Fiorito S, Bonini S, Vigneti E, Aloe L. Nerve growth factor release by human synovial fibroblasts prior to and following exposure to tumor necrosis factoralpha, interleukin-1 beta and cholecystokinin-8: The possible role of NGF in the inflammatory response. Clin Exp Rheumatol 2003;21:617-624
9. Levi-Montalcini R, Aloe L, Alleva E. A role for nerve growth factor in nervous, endocrine and immune systems. Prog Neuroendocrine Immunol 1990;3:1-10.
10. Valencia X, Higgins JMG, Kiener HP, Lee DM, Podrebarac TA, Dascher CC, et al. Cadherin-11 provides specific cellular adhesion between fibroblast-like synoviocytes. J Exp Med 2004;200:1673-1679
11. Shang XZ, Lang BJ, Issekutz AC. Adhesion molecule mechanisms mediating monocyte migration through synovial fibroblast and endothelium barriers: Role for CD11/CD18, very late antigen-4 (CD49d/CD29), very late antigen-5 (CD49e/ CD29), and vascular cell adhesion molecule-1 (CD106). J Immunol 1998;160:467-474
12. Giatromanolaki A, Sivridis E, Athanassou N, Zois E, Thorpe PE, Brekken RA, et al. The angiogenic pathway 'vascular endothelial growth factor/flk-1 (KDR)-receptor' in rheumatoid arthritis and osteoarthritis. J Pathol 2001;194: 101-108
13. Tang LL, Wang R, Tang XC. Huperzine A protects SHSY5Y neuroblastoma cells against oxidative stress damage via nerve growth factor production. Eur J Pharmacol 2005;519:9-15.
14. Olivieri G, Otten U, Meier F, Baysang G, Dimitriades-Schmutz B, Müller-Spahn F, et al. Oxidative stress modulates tyrosine kinase receptor A and p75 receptor (low-affinity nerve growth factor receptor) expression in SHSY5Y neuroblastoma cells. Neurol Clin Neurophysiol 2002;2:2-10.
15. Otten U, Scully JL, Ehrhard PB, Gadient RA. Neurotrophins: signals between the nervous and immune systems. Prog Brain Res 1994;103:293-305.
16. Horigome K, Pryor JC, Bullock ED, Johnson EM. Mediator release from mast cells by nerve growth factor. Neurotrophin specificity and receptor mediation. J Biol Chem 1993;268: 14881-14887
17. Pincelli C, Sevignani C, Manfredini R, Grande A, Fantini F, Bracci-Laudiero L, et al. Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes. J Invest Dermatol 1994;103:13-18.
18. Yaar M, Eller MS, DiBenedetto P, Reenstra WR, Zhai S, McQuaid T, et al. The trk family of receptors mediates nerve growth factor and neurotrophin-3 effects in melanocytes. J Clin Invest 1994;94:1550-1562
19. Raychaudhuri SK, Raychaudhuri SP, Weltman H, Farber EM. Effect of nerve growth factor on endothelial cell biology: proliferation and adherence molecule expression on human dermal microvascular endothelial cells. Arch Dermatol Res 2001;293:291-295
20. Meakin SO, Shooter EM. The nerve growth factor family of receptors. Trends Neurosci 1992;15:323-331
21. Patterson JC, Childs GV. Nerve growth factor and its receptor in the anterior pituitary. Endocrinology 1994;135:1689-1696
22. Raychaudhuri SP, Sanyal M, Weltman H, Raychaudhuri SK. K252a, a high affinity NGF receptor blocker improves psoriasis: An in vivo study using the SCID mouse-human skin model. J Invest Dermatol 2004;122:812-819
23. El-Banna SM, Mahdi WK, Ali BA, Raouf MM. Role of nerve growth factor in allergic and inflammatory lung diseases. J Microbiol Immunol Infect 2006;39:444-451
24. Johansson M, Norrgard O, Forsgren S. Study of expression patterns and levels of neurotrophins and neurotrophin receptors in ulcerative colitis. Inflamm Bowel Dis 2007;13:398-409.
25. Ulrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990;61:203-212
26. Berg MM, Sternberg DW, Parada LF, Chao MV. K-252a inhibits nerve growth factor-induced trk proto-oncogene tyrosine phosphorylation and kinase activity. J Biol Chem 1992;267:13-16.
27. Dicou E, Masson C, Jabbour W, Nerriere V. Increased frequency of NGF in sera of RA and systemic lupus erythematosus patients. Neuroreport 1993;5:321-324
28. Halliday DA, Zettler C, Rush RA, Scicchitano R, McNeil JD. Elevated nerve growth factor levels in the synovial fluid of patients with inflammatory joint disease. Neurochem Res 1998;23:919-922
29. Del Porto F, Aloe L, Lagana B, Triaca V, Nofroni I, D'Amelio R. Nerve growth factor and brain-derived neurotrophic factor levels in patients with rheumatoid arthritis treated with TNF-alpha blockers. Ann N Y Acad Sci 2006;1069:438-443
30. Rihl M, Kruithof E, Barthel C, De Keyser F, Veys EM, Zeidler H, et al. Involvement of neurotrophins and their receptors in spondyloarthritis synovitis: Relation to inflammation and response to treatment. Ann Rheum Dis 2005;64:1542-1549
31. Wernicke D, Schulze-Westhoff C, Petrow P, Bräuer R, Zacher J, Gay S, et al. Stimulation of collagenase 3 expression in synovial fibroblasts of patients with rheumatoid arthritis by contact with a three-dimensional collagen matrix or with normal cartilage when coimplanted in NOD/SCID mice. Arthritis Rheum 2002;46:64-74.
32. Turan B, Pfister K, Diener PA, Hell M, Möller B, Boyvat A, et al. Soluble tumour necrosis factor receptors sTNFR1 and sTNFR2 are produced at sites of inflammation and are markers of arthritis activity in Behçet's disease. Scand J Rheumatol 2008;37:135-141
33. Jiao Z, Wang W, Jia R, Li J, You H, Chen L, Wang Y. Accumulation of FoxP3-expressing CD4+CD25+ T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis. Scand J Rheumatol 2007;36:428-433
34. Nguyen TT, Gehrmann M, Zlacka D, Sosna A, Vavrincova P, Multhoff G, et al. Heatshock protein 70 membrane expression on fibroblast-like synovial cells derived from synovial tissue of patients with rheumatoid and juvenile idiopathic arthritis. Scand J Rheumatol 2006;35:447-453
35. Cinelli M, Guiducci S, Del Rosso A, Pignone A, Del Rosso M, Fibbi G, et al. Piascledine modulates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes. Scand J Rheumatol 2006;35:346-350
36. ThorpeLW,Werrbach-Perez K, Perez-Polo JR. Effects of nerve growth factor on the expression of IL-2 receptors on cultured human lymphocytes. Ann N Y Acad Sci 1987;496:310-311
37. Raychaudhuri SP, Jiang WY, Farber EM, Schall TJ, Ruff MR, Pert CB. Upregulation of RANTES in psoriatic keratinocytes: A possible pathogenic mechanism for psoriasis. Acta Derm Venereol 1999;79:9-11.
38. Lindsay RM, Harmar AJ. Nerve growth factor regulates expression of neuropeptides genes in adult sensory neurons. Nature 1989;337:362-364
39. Indo Y. Genetics of congenital insensitivity to pain with anhidrosis (CIPA) or hereditary sensory and autonomic neuropathy type IV. Clinical, biological and molecular aspects of mutations in TRKA(NTRK1) gene encoding the receptor tyrosine kinase for nerve growth factor. Clin Auton Res 2002;12(Suppl 1):I20-32.
40. Lewin GR, Rueff A, Mendell LM. Peripheral and central mechanisms of NGF induced hyperalgesia. Eur J Neurosci 1994;6:1903-1912